Inventor
VISWANATHAN KARTHIK
US51 patents
⚠️ This page may combine multiple inventors who share the name “VISWANATHAN KARTHIK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
VISTERRA INC
29 patentsUS9212217B2Dec 15, 2015
Antibody molecules to dengue virus and uses thereof
VISTERRA INC14 citations92
US9096657B2Aug 4, 2015
HA binding agents
VISTERRA INC13 citations92
US8877200B2Nov 4, 2014
HA binding agents
VISTERRA INC17 citations92
US10800835B2Oct 13, 2020
HA binding agents
VISTERRA INC4 citations84
US9969794B2May 15, 2018
HA binding agents
VISTERRA INC7 citations84
US11136385B2Oct 5, 2021
Methods of treating IgA nephropathy by administering an anti-APRIL (a proliferation-inducing ligand) antibody molecule
VISTERRA INC4 citations83
US10954296B2Mar 23, 2021
Method of using anti-APRIL (a proliferation-inducing ligand) antibodies to reduce IGA
VISTERRA INC4 citations83
US10385123B2Aug 20, 2019
Antibody molecules to a proliferation-inducing ligand (APRIL)
VISTERRA INC8 citations83
US10155806B2Dec 18, 2018
Antibody molecules to dengue virus and uses thereof
VISTERRA INC4 citations83
US9365639B2Jun 14, 2016
Antibody molecules to dengue virus and uses thereof
VISTERRA INC9 citations83
US11059883B2Jul 13, 2021
Antibody molecules to dengue virus and uses thereof
VISTERRA INC2 citations72
US10981982B2Apr 20, 2021
Nucleic acid molecules encoding antibodies to a proliferation-inducing ligand (APRIL)
VISTERRA INC1 citations72
US10968270B2Apr 6, 2021
Antibody molecules to a proliferation-inducing ligand (APRIL)
VISTERRA INC3 citations72
US11912781B2Feb 27, 2024
Humanized complement 5A receptor 1 antibodies and methods of use thereof
VISTERRA INC1 citations71
US11168131B2Nov 9, 2021
Antibody molecule-drug conjugates and uses thereof
VISTERRA INC4 citations69
US10513553B2Dec 24, 2019
Compositions and methods for treating and preventing influenza
VISTERRA INC6 citations67
US12054539B2Aug 6, 2024
Antibody molecules to dengue virus and uses thereof
VISTERRA INC0 citations62
US12024552B2Jul 2, 2024
Ha binding agents
VISTERRA INC0 citations62
US12415865B2Sep 16, 2025
Antibody molecules to C5AR1 and uses thereof
VISTERRA INC0 citations61
US12187807B2Jan 7, 2025
Antibody molecules to C5AR1 and uses thereof
VISTERRA INC0 citations61
US12091451B2Sep 17, 2024
Method of using antibody molecules to detect a proliferation-inducing ligand (APRIL)
VISTERRA INC0 citations61
US11773179B2Oct 3, 2023
Antibody molecules to C5aR1 and uses thereof
VISTERRA INC0 citations61
US12338291B2Jun 24, 2025
Humanized antibody molecules to CD138 and uses thereof
VISTERRA INC0 citations60
US12264203B2Apr 1, 2025
Humanized complement 5a receptor 1 antibodies and methods of use thereof
VISTERRA INC0 citations60
US12227587B2Feb 18, 2025
Humanized complement 5A receptor 1 antibodies and methods of use thereof
VISTERRA INC0 citations60
US11945868B2Apr 2, 2024
Antibody molecules to CD138 and uses thereof
VISTERRA INC1 citations59
US11858980B2Jan 2, 2024
Engineered polypeptides and uses thereof
VISTERRA INC0 citations59
US11890319B2Feb 6, 2024
Antibody molecule-drug conjugates and uses thereof
VISTERRA INC0 citations49
US11969476B2Apr 30, 2024
Antibody molecule-drug conjugates and uses thereof
VISTERRA INC0 citations46
DONALDSON CO INC
6 patentsUS9789435B2Oct 17, 2017
Materials, methods, and devices for siloxane contaminant removal
DONALDSON CO INC4 citations82
US11648501B2May 16, 2023
Materials, methods, and devices for siloxane contaminant removal
DONALDSON CO INC1 citations71
US10688433B2Jun 23, 2020
Materials, methods, and devices for siloxane contaminant removal
DONALDSON CO INC1 citations71
US10130905B2Nov 20, 2018
Materials, methods, and devices for siloxane contaminant removal
DONALDSON CO INC2 citations71
US12151198B2Nov 26, 2024
Materials, methods, and devices for siloxane contaminant removal
DONALDSON CO INC0 citations60
US10213711B2Feb 26, 2019
Filter assembly for removing high molecular weight hydrocarbons from liquified propane gas
DONALDSON CO INC0 citations51
MASSACHUSETTS INST TECHNOLOGY
4 patentsUS9572861B2Feb 21, 2017
Engineered polypeptide agents for targeted broad spectrum influenza neutralization
MASSACHUSETTS INST TECHNOLOGY6 citations83
US9334309B2May 10, 2016
Engineered polypeptide agents for targeted broad spectrum influenza neutralization
MASSACHUSETTS INST TECHNOLOGY6 citations83
US9709567B2Jul 18, 2017
Compositions and methods for diagnosing and/or treating influenza infection
MASSACHUSETTS INST TECHNOLOGY6 citations81
US9745352B2Aug 29, 2017
Influenza treatment and/or characterization, human-adapted HA polypeptides; vaccines
MASSACHUSETTS INST TECHNOLOGY5 citations70
SASISEKHARAN RAM
2 patentsBOSQUES CARLOS
1 patentRAMAN RAHUL
1 patentJAYARAMAN AKILA
1 patentBLAISDELL JARED DEAN
1 patentTHARAKARAMAN KANNAN
1 patentNIIT TECH LTD
1 patentFRESHDESK INC
1 patentCHARLES STARK DRAPER LABORATORY INC
1 patentFORD GLOBAL TECH LLC
1 patentShowing the top 50 of 51 patents by PatentIndex Score.